Seasonal Influenza Vaccination Resources for Health Professionals

On October 24, 2007 CDC's Advisory Committee on Immunization Practices (ACIP) recommended expanding the use of the nasal influenza vaccine LAIV (FluMist®) to include healthy children ages 2-4 years old (24-59 months old) without a history of asthma or recurrent wheezing. The vaccine continues to be recommended for healthy persons ages 5-49 years who are not pregnant. "Healthy" indicates persons who do not have an underlying medical condition that predisposes them to influenza complications.

On this page:

• Influenza Vaccination: Summary for Clinicians
• 2007-08 Recommendations of the Advisory Committee On Immunization Practices (ACIP)
• Dosage & Administration
• Composition of 2007-08 Vaccine
• Supply & Distribution
• Storage & Handling
• Coverage Levels
• Effectiveness & Safety
• Patient Education
• Related Resources
• Next Season: 2008-2009 Influenza Season

Influenza Vaccination: Summary for Clinicians

• Influenza Vaccination: Summary for Clinicians

2007-08 Recommendations of the Advisory Committee On Immunization Practices (ACIP)

• Prevention & Control of Influenza - Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  Information for the 2007-08 season including vaccine composition, dosage & administration, recommendations for specific populations, and more.

Dosage & Administration

• ACIP: Dosage, Administration, and Storage
• ACIP: Persons for Whom Annual Vaccination is Recommended
• ACIP: Recommendations for Using TIV and LAIV During the 2007-08 Influenza Season
  Target groups for vaccination.
• ACIP: Vaccination of Specific Populations
  Children, persons aged 50-64 years, healthcare personnel, close contacts of immunocompromised persons, pregnant women, breastfeeding mothers, travelers, and the general population.
• ACIP: Timing of Vaccination
• Dosage & Administration (Q&A)
• 2007–08 Influenza Vaccine Dosage Chart   

Composition of 2007-08 Vaccine

• ACIP: Influenza Vaccine Composition & Major Differences
  Includes major differences between inactivated vaccine (TIV) and live attenuated influenza vaccine (LAIV).
• The Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV]) (Q&A)
• Selecting the Viruses in the Influenza (Flu) Vaccine (Q&A)

Supply & Distribution

• ACIP: Influenza Vaccine Supply Considerations
• Vaccine Supply for the U.S. 2007-08 Influenza Season (Q&A)
• Supply & Distribution in the U.S. (Q&A)
• Distributors
  Listing from the Health Industry Distributors Association

Storage & Handling

• ACIP: Dosage, Administration, and Storage
• Large-Scale Influenza Vaccination Clinic Planning
• Packing, Shipping, Handling, & Storing Influenza Vaccine
  Guidelines for packing, shipping, handling, & storage of vaccine; vaccines are listed alphabetically.
• Influenza Vaccine Availability Tracking System (IVATS)
  A resource to enable healthcare providers to find influenza vaccine to purchase.

Coverage Levels

• ACIP: Vaccination Coverage Levels
• Influenza: Self-Reported Vaccination Coverage Trends 1989 - 2006   
• Pneumococcal: Self-Reported Pneumococcal Vaccination Coverage Trends 1989 - 2006   
• Estimates of Target Population Sizes in 2006 & Recent Vaccine Uptake Levels   

Effectiveness & Safety

• ACIP: Comparisons of LAIV and TIV Efficacy
• ACIP: Persons Who Should Not Be Vaccinated
• ACIP: Adverse Events After Receipt of TIV
• ACIP: Adverse Events After Receipt of LAIV
• Flu Vaccine Effectiveness (Q&A for Health Professionals)
• Recent Study of Impact of Flu Vaccination on Seasonal Mortality of Elderly   
• Vaccine Adverse Event Reporting System (VAERS)
  Also available by telephone at 1-800-822-7967

Patient Education

• Free Flu Materials: CDC's Flu Gallery
• Key Facts about Seasonal Influenza (Q&A)
• Flu Vaccine (Q&A)
• How Well Does the Flu Vaccine Work? (Q&A)
• The Flu Shot (Q&A)
• Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV]) (Q&A)
• Thimerosal in Seasonal Influenza Vaccine (Q&A)
• Seasonal Flu and Guillain-Barré Syndrome (GBS) (Q&A)
• Inactivated Flu Vaccine: Vaccination Information Statement (VIS)   
• Live, Intranasal Flu Vaccine: Vaccination Information Statement (VIS)   

Related Resources

• Flu Research and Vaccine Development (Q&A)
• MMWR Reports & Recommendations from Past Flu Seasons

Next Season: 2008-09 Influenza Season

• FDA: 2008-09 Influenza Vaccine Composition
• CDC’s Advisory Committee Recommends Influenza Vaccination for Children 6 months through 18 years of age
• Podcast: Influenza Vaccination Now Recommended for Children 6 months to 18 years of Age

• Page last updated February 29, 2008
• Content Source: Coordinating Center for Infectious Diseases (CCID)
• National Center for Immunization and Respiratory Diseases (NCIRD)

• Email page
• Print page
• Get Email Updates
• RSS

What You Should Know About …

Info for Health Professionals

• 2007-08 ACIP Recommendations
• Vaccination
• Antiviral Drugs
• Infection Control
• Clinical Description & Lab Diagnosis
• Free Flu Materials
• 2008 National Influenza Vaccination Week (NIVW)
• Flu Activity & Surveillance
• Training
• References & Resources

Info for Specific Groups

Other Flu Websites

• Avian Flu
• Pandemic Flu
• Swine Flu

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800–CDC–INFO (800-232-4636), 888–232–6348 (TTY), cdcinfo@cdc.gov